A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause
Clinical trial NCT04003389 · COMPLETED
Trial details
- NCT number
- NCT04003389
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-10
- Primary completion
- 2022-01-04
- Enrollment
- 1831
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.